ClinConnect ClinConnect Logo
Search / Trial NCT03225586

Prospective Urban Rural Epidemiology Study

Launched by POPULATION HEALTH RESEARCH INSTITUTE · Jul 19, 2017

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

Non Communicable Diseases, Risk Factors

ClinConnect Summary

The Prospective Urban Rural Epidemiology Study is a research trial aimed at understanding how different factors affect our health, particularly focusing on heart diseases and other serious illnesses. Researchers want to learn about how personal choices, like what we eat and how active we are, as well as broader environmental factors, such as air quality and healthcare policies, influence health outcomes like disease development and mortality rates. The study will also look at genetic factors that may contribute to these non-communicable diseases.

If you're an adult aged between 35 and 70 and are interested in participating, you might be a good fit for this study. There are no specific exclusions, so virtually anyone in that age range can join. As a participant, you can expect to provide information about your health behaviors and possibly undergo some health assessments. This research is currently recruiting participants, and it aims to gather valuable insights that could improve our understanding of health across different communities.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • consenting adults between 35-70 years of age
  • Exclusion Criteria:
  • none

About Population Health Research Institute

The Population Health Research Institute (PHRI) is a leading clinical research organization dedicated to advancing the understanding of population health through innovative research methodologies. With a focus on large-scale, multi-center clinical trials and epidemiological studies, PHRI aims to address pressing health challenges by investigating the interplay between lifestyle, genetic, and environmental factors. By fostering collaboration among researchers, healthcare providers, and communities, PHRI strives to generate evidence-based insights that inform public health policies and improve health outcomes on a global scale. Their commitment to excellence in research is underscored by a robust infrastructure and a multidisciplinary team of experts dedicated to translating research findings into actionable solutions for diverse populations.

Locations

Lima, , Peru

Karachi, , Pakistan

Harare, , Zimbabwe

Riyadh, , Saudi Arabia

Isfahan, , Iran, Islamic Republic Of

Hamilton, Ontario, Canada

Rosario, Santa Fe, Argentina

Dhaka, , Bangladesh

São Paulo, , Brazil

Vancouver, British Columbia, Canada

Ottawa, Ontario, Canada

Quebec City, Quebec, Canada

Temuco, , Chile

Beijing, , China

Floridablanca, Santander, Colombia

Bangalore, Karnataka, India

Thiruvananthapuram, Kerala, India

Jaipur, Rajasthan, India

Chennai, Tamil Nadu, India

Chandigarh, , India

Almaty, , Kazakhstan

Bishkek, , Kyrgyzstan

Kuala Lumpur, , Malaysia

Kuala Lumpur, , Malaysia

Ramallah, , Palestinian Territory, Occupied

Manila, , Philippines

Wrocław, , Poland

Kemerovo, , Russian Federation

Bellville, , South Africa

Potchefstroom, , South Africa

Göteborg, , Sweden

Moshi, , Tanzania

İstanbul, , Turkey

Dubai, , United Arab Emirates

Patients applied

0 patients applied

Trial Officials

Salim Yusuf, DPhil

Principal Investigator

Executive Director

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials